Home > List All Publishers > BioSeeker Group AB

BioSeeker Group AB

BioSeeker Group is a business and competitive intelligence company for investment, venture and R&D management of biotechnology and pharmaceutical companies. It serves the needs of individuals, companies, and institutional clients with a diverse range of information and analysis services.
BioSeeker Group has a strong client focus providing decision-makers, investors, and management people with candid, credible research coverage on biotechnology and pharmaceutical companies. The firm is committed to creating value for clients by providing wisdom and high quality services that meet clients' needs. BioSeeker Group clients and projects are kept confidential.

List of reports from BioSeeker Group AB

Triple Analysis: Apoptosis, Cancer Vaccines and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| more...	$5,175.00
Triple Analysis: Angiogenesis, Cancer Vaccines and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| more...	$5,175.00
Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ... \| more...	$5,175.00
Triple Analysis: Angiogenesis, Antibodies and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| more...	$5,175.00
Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| more...	$5,175.00
Analytical Tool - Antibodies and Peptides in Oncology 1/7/2013 \| published by: BioSeeker Group AB ... competitive landscape. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product ... \| more...	$8,925.00
Triple Analysis: Apoptosis, Angiogenesis and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ... \| more...	$5,175.00
Cancer Peptides: From First-in-Class to Best-in-Class? 1/7/2013 \| published by: BioSeeker Group AB ... Which targets, tumor types and companies are setting the path? What is first-in-class in the cancer peptide pipeline? Is First-in-Class the Best-in-Class? Indication expansion opportunities Drug repositioning opportunities Which pathways are targeted, by what and ... \| more...	$3,675.00
Triple Analysis: Colorectal Cancer, Leukemia and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| more...	$5,175.00
Triple Analysis: Colorectal Cancer, Melanoma and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| more...	$5,175.00
Triple Analysis: Colorectal Cancer, Prostate Cancer and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| more...	$5,175.00
Triple Analysis: Colorectal Cancer, Apoptosis and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| more...	$5,175.00
Triple Analysis: Colorectal Cancer, Cancer Vaccines and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ... \| more...	$5,175.00
Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ... \| more...	$5,175.00
Triple Analysis: Leukemia, Lung Cancer and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| more...	$5,175.00
Triple Analysis: Leukemia, Pancreatic Cancer and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| more...	$5,175.00
Triple Analysis: Leukemia, Apoptosis and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ... \| more...	$5,175.00
Triple Analysis: Leukemia, Angiogenesis and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ... \| more...	$5,175.00
Triple Analysis: Lung Cancer, Pancreatic Cancer and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| more...	$5,175.00
Triple Analysis: Lung Cancer, Prostate Cancer and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| more...	$5,175.00
Triple Analysis: Lung Cancer, Apoptosis and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| more...	$5,175.00
Triple Analysis: Lymphoma, Prostate Cancer and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| more...	$5,175.00
Triple Analysis: Lymphoma, Angiogenesis and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ... \| more...	$5,175.00
Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ... \| more...	$5,175.00
Triple Analysis: Melanoma, Prostate Cancer and Peptides 1/7/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| more...	$5,175.00

< prev 1 2 3 4 5 6 7 8 9 10 next >

BioSeeker Group AB

List of reports from BioSeeker Group AB

Research assistance

Join Alert Me now!